关于侵袭性复发性缓解性多发性硬化症的事实和神话 - 目前的知识状况和未来的前景
Klara Dyczkowska1,2, Alicja Kalinowska3
1Department of Neurology, Division of Neurochemistry and Neuropathology, Poznan University of Medical Sciences, Poznan, Poland.
Neurologia i neurochirurgia polska
|December 31, 2024
概括
识别侵袭性多发性硬化症 (MS) 对于治疗决策至关重要. 本综述评估了对侵袭性多发性硬化症的研究,以帮助临床医生平衡个体患者的治疗风险和益处.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 临床神经学 临床神经学
背景情况:
- 多发性硬化症 (MS) 是年轻人神经障碍的主要原因,影响中枢神经系统 (CNS).
- 疾病修饰疗法 (DMT) 主要使用免疫调节或免疫抑制机制来控制MS.
- 在低于最佳反应后的传统治疗升级可能对激进的MS病例不够.
研究的目的:
- 审查和评价现有关于侵袭性多发性硬化症的研究.
- 确定有关侵袭性疾病过程的关键发现和知识差距.
- 为了帮助临床医生评估积极性多发性硬化症治疗的益处风险比率.
主要方法:
- 科学文献的叙述性审查.
- 专注于研究有关侵袭性多发性硬化症表型的研究.
- 评估与疾病进展和治疗策略相关的发现.
主要成果:
- 该审查综合了对侵略性MS的当前理解.
- 它强调了识别那些可以从早期高效疗法 (HET) 中受益的患者所面临的挑战.
- 确定了关于风险分层和最佳治疗启动的知识差距.
结论:
- 准确识别侵略性多发性硬化症对于个性化治疗策略至关重要.
- 需要进一步的研究来完善风险评估和指导使用HET.
- 与潜在的风险和成本平衡治疗疗效仍然是一个关键的临床挑战.
相关概念视频
Parkinson's Disease: Overview
303
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
303
Amyloid Fibrils
9.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.0K
Psychosis and Antipsychotic Drugs: Overview
151
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
151
Classification of Illness
7.1K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
7.1K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
253
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
253
Myasthenia Gravis: Overview and Treatment
932
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
932


